Meet us at booth #08

September 24-26, 2025
CCIB Barcelona International Convention Center

ectrims mMD-1
62b19116e08d625019b7103a_Phil Norris-p-500-3

 

Phil Norris

Chief Commercial Officer

62b1900ffd94c5804f75e495_Dr. Pia Massatsch

Dr.

Pia Massatsch

Head of Clinical Affairs

62b1902a69301e757dfcd981_Dr. Dominik Brügger

Dr.

Dominik Brügger

Chief Technology Officer

Our conference highlight


Validation of RAPD  neoscore: A Novel Digital Biomarker for Detecting Relative Afferent Pupillary Defect
Presented by Dominik Brügger

Paper Poster Session 1 - Wednesday, 24 September 2025
POSTER ID P274
Imaging and Non-imaging Biomarkers - Other Biomarkers

machineMD Bochum RAPD Poster-ECTRIMS 2025

Optic Nerve

The fifth topology in the 2024 McDonald diagnostic criteria1

Optic neuritis is one of the most common forms of presentation in multiple sclerosis: in 25% of new MS cases optic neuritis is the initial clinical event. Moreover, studies show that 50-70% of all patients with MS will experience optic neuritis at some stage of the condition. Optic neuritis presents with acute unilateral vision loss2 - 4. Visual field defects are present in almost all patients with optic neuritis (97.5%)2. Relative afferent pupillary defects (RAPD) occur in 96% of acute unilateral optic neuritis cases5, and assessing RAPD is a critical element in the diagnosis and classification of optic neuritis6.

 

 

The most frequently observed eye movement disorders in MS are saccadic dysmetria (91%), INO (68%), vestibulo-ocular reflex abnormalities and gaze-evoked nystagmus (36%), fixation instability, and impaired smooth pursuit 2,7 . Up to 71% of INOs are not detected in routine clinical assessment8.

 

 

1 Montalban, Xavier et al.  Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
2
Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005;4(2):111-121. 

3 Dhanapalaratnam R, Markoulli M, Krishnan AV. Disorders of vision in multiple sclerosis. Clin Exp Optom. 2022;105(1):3-12.
4 Sheehy CK, Beaudry-Richard A, Bensinger E, Theis J, Green AJ. Methods to Assess Ocular Motor Dysfunction in Multiple Sclerosis. J Neuroophthalmol. 2018;38(4):488-493.
5 Cox TA, Thompson HS, Corbett JJ. Relative afferent pupillary defects in optic neuritis. Am J Ophthalmol. 1981;92(5):685-690. 

6 Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120-1134.
7 Niestroy A, Rucker JC, Leigh RJ. Neuro-ophthalmologic aspects of multiple sclerosis: Using eye movements as a clinical and experimental tool. Clin Ophthalmol. 2007;1(3):267-272.
8 Frohman TC, Frohman EM, O'Suilleabhain P, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology. 2003;61(6):848-850. 

neos_tm

8 exams in under 12 minutes:

neos checkgaze holding

neos checkocular alignment

neos checkfusional amplitudes

neos checksaccades

neos checksmooth pursuit

neos checkvisual field screening

neos checkafferent pupillary function

neos checkefferent pupillary function

clock_icon Fast    brain_mixorangeblack_icon Automated    data_icon Quantitative

Let's keep in touch!

Please share your details with the machineMD team via the form below to learn more about clinical and research possibilities with neos